At BioAsia 2025, our booth served as a hub for meaningful discussions and industry networking. We engaged with biopharma professionals, investors, and researchers, exploring collaborations in clinical trials, regulatory strategies, and AI-driven healthcare innovations. Visitors to our booth showed keen interest in our expertise in clinical trials, clinical development, medical writing, regulatory negotiations, pharmacovigilance, and medical research advancements.

Through interactive sessions and one-on-one discussions, we fostered valuable connections, exchanged insights on emerging trends in biotech and life sciences, and strengthened strategic partnerships. BioAsia 2025 provided an excellent platform to showcase our commitment to driving innovation in healthcare.

Our team represented by Dr. Deepa Arora MD (CEO of CLINEXEL) Dr Mukesh Kumar, M.D. (Chief Scientific Officer, CLINEXEL) Dr Ranjit Chavan (Global Head- Drug Safety, CLINEXEL) and Md Nabid (Director -Quality Management Systems, CLINEXEL).